Please use this identifier to cite or link to this item: https://doi.org/10.1016/j.neuropharm.2007.08.012
Title: Two-methyl-6-phenylethynyl-pyridine (MPEP), a metabotropic glutamate receptor 5 antagonist, with low doses of MK801 and diazepam: A novel approach for controlling status epilepticus
Authors: Tang, F.R. 
Chen, P.M.
Tang, Y.C.
Tsai, M.C.
Lee, W.L.
Keywords: Group I metabotropic glutamate receptor
MPEP
Neuroprotection
Status epilepticus
Issue Date: Dec-2007
Citation: Tang, F.R., Chen, P.M., Tang, Y.C., Tsai, M.C., Lee, W.L. (2007-12). Two-methyl-6-phenylethynyl-pyridine (MPEP), a metabotropic glutamate receptor 5 antagonist, with low doses of MK801 and diazepam: A novel approach for controlling status epilepticus. Neuropharmacology 53 (7) : 821-831. ScholarBank@NUS Repository. https://doi.org/10.1016/j.neuropharm.2007.08.012
Abstract: By intravenous administration of group I metabotropic glutamate receptor antagonists at 1 or 2 h during pilocarpine induced status epilepticus (PISE), we showed that mGluR1 antagonists AIDA or LY367385 (at dosages ranging from 25 to 200 mg/kg), mGluR5 antagonists SIB1757 (at dosages ranging from 25 to 200 mg/kg), SIB1893 (from 25 to 100 mg/kg), MPEP (from 25 to 100 mg/kg) injected at 1 or 2 h during PISE were ineffective in controlling status epilepticus (SE). However, when administered at 1 h during PISE, MPEP at 200 mg/kg, combination of MPEP (200 mg/kg) with MK801 (0.1 mg/kg) or with MK801 (0.1 mg/kg) and diazepam (0.5 mg/kg), combination of SIB1893 (200 mg/kg) with MK801 (0.1 mg/kg) could effectively control behavioral SE, and were neuroprotective. In particular, the combination of MPEP with MK801 and diazepam could stop both behavioral SE and electrical SE (under EEG monitoring) within a few minutes after the administration. HPLC study showed that a high level of MPEP was maintained in the blood and its metabolism rate was slow in experimental mice with PISE. We therefore concluded that the combination of MPEP (200 mg/kg) with MK801 (0.1 mg/kg) and diazepam (0.5 mg/kg) could effectively stop SE and its subsequent neuronal loss in the hippocampus when administered 1 h during PISE. It may provide a new approach to effectively control intractable SE. © 2007 Elsevier Ltd. All rights reserved.
Source Title: Neuropharmacology
URI: http://scholarbank.nus.edu.sg/handle/10635/109721
ISSN: 00283908
DOI: 10.1016/j.neuropharm.2007.08.012
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

19
checked on Jun 13, 2018

WEB OF SCIENCETM
Citations

18
checked on Apr 30, 2018

Page view(s)

51
checked on May 11, 2018

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.